Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/24/2012 | WO2012065937A1 Anti-fungal agents |
05/24/2012 | WO2012065852A2 Therapeutic protein |
05/24/2012 | WO2012065262A1 Expression, purification and refolding of recombinant chlamydia proteins, compositions and related methods |
05/24/2012 | WO2012065248A1 Method for increasing neprilysin expression and activity |
05/24/2012 | WO2012046006A3 Cutaneous squamous cell carcinoma target sequences |
05/24/2012 | WO2012038832A3 Generation of replicating chimeric measles virus - retrovirus particles |
05/24/2012 | WO2012035120A3 Screening method |
05/24/2012 | WO2012024309A3 Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
05/24/2012 | US20120131697 Gene encoding auxin receptor protein derived from rice and use thereof |
05/24/2012 | US20120131696 Polynucleotides and polypeptides for increasing desirable plant qualities |
05/24/2012 | US20120131687 Agent that modulates physiological condition of pests, involved in insect voltage-gated potassium channel activity |
05/24/2012 | US20120130051 Astringency in soy protein solutions |
05/24/2012 | US20120130048 Process for extracting keratin |
05/24/2012 | US20120130047 Accelerated gelation of regenerated fibroin |
05/24/2012 | US20120130046 Tropoelastin derivatives |
05/24/2012 | US20120130045 Biomolecule-polymer conjugates and methods of making same |
05/24/2012 | US20120130044 Stable Analogs of Peptide and Polypeptide Therapeutics |
05/24/2012 | US20120129915 Organic compositions to treat hsf1-related diseases |
05/24/2012 | US20120129790 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
05/24/2012 | US20120129778 Ligand that bind tgf-beta receptor rii |
05/24/2012 | US20120129776 Bioactive peptides and method of using same |
05/24/2012 | US20120129771 Peptides and related molecules that modulate nerve growth factor activity |
05/24/2012 | US20120129770 Novel polynucleotide molecules for enhanced gene expression |
05/24/2012 | US20120129768 Glp-1 analogues and their pharmaceutical salts and uses |
05/24/2012 | US20120129766 Methods of treating fgf21-associated disorders |
05/24/2012 | US20120129764 Influenza a and b virus replication-inhibiting peptides |
05/24/2012 | US20120129762 Motilin-like peptide compound having transmucosal absorbability imparted thereto |
05/24/2012 | US20120129759 Protein surface remodeling |
05/24/2012 | US20120129724 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells |
05/24/2012 | US20120129264 Method for Transforming a Bacterium Belonging to the Streptococcus Genus by Natural Competence |
05/24/2012 | US20120129254 Inducible Expression System Transcription Modulators Comprising A Distributed Protein Transduction Domain And Methods For Using The Same |
05/24/2012 | US20120129241 An l-arabinose fermenting yeast |
05/24/2012 | US20120129184 Systemic carnitine deficiency gene and uses thereof |
05/24/2012 | US20120129167 Truncated cd20 protein, deltacd20 |
05/24/2012 | US20120129150 Particles embedded in a porous substrate for removing target analyte from a sample |
05/24/2012 | US20120128756 Skin Permeating And Cell Entering (SPACE) Peptides and Methods of Use Thereof |
05/24/2012 | US20120128709 Expression of recombinant proteins |
05/24/2012 | US20120128708 Diagnostic mycobacterium tuberculosis test |
05/24/2012 | US20120128707 Streptococcus pneumoniae proteins and nucleic acids |
05/24/2012 | US20120128704 Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof |
05/24/2012 | US20120128700 Constructs for delivery of therapeutic agents to neuronal cells |
05/24/2012 | US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
05/24/2012 | US20120128682 Apolipoprotein l- i variants and their use |
05/24/2012 | US20120128677 Pancreatic cancer targets and uses thereof |
05/24/2012 | US20120128629 Method of labelling interferons with peg |
05/24/2012 | US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof |
05/24/2012 | US20120128624 Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects |
05/24/2012 | US20120128597 Composition for prevention and treatment of allergic and/or inflammatory diseases |
05/24/2012 | US20120125788 Electrochemical affinity biosensor system and methods |
05/24/2012 | CA2818353A1 Methods and compositions for inducing an immune response to egfrviii |
05/24/2012 | CA2818253A1 Method for increasing neprilysin expression and activity |
05/24/2012 | CA2817933A1 New ethiological agent |
05/24/2012 | CA2817786A1 Methods of treating fgf21-associated disorders |
05/24/2012 | CA2817779A1 Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3) |
05/24/2012 | CA2817355A1 Methods and compositions for modulating pd1 |
05/24/2012 | CA2817096A1 A process for reduction and/or removal of fxi and fxia from solutions containing said coagulation factors |
05/23/2012 | EP2455758A1 Method for measurement of glycoprotein, method for detection of hepatic diseases, reagent for quantification of glycoprotein, and sugar chain marker glycoprotein as measure of disease conditions of hepatic diseases |
05/23/2012 | EP2455750A1 Method for specific cleavage of n-c bond in peptide main chain |
05/23/2012 | EP2455469A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof |
05/23/2012 | EP2455397A1 Mutant ras polypeptide crystal |
05/23/2012 | EP2455396A1 Sugar chain-added ailim extracellular domain and method for producing same |
05/23/2012 | EP2455395A1 MCM6 monoclonal antibodies and methods for their use in the detection of cervical disease |
05/23/2012 | EP2455394A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455393A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455392A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455391A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455390A1 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
05/23/2012 | EP2455389A1 Sugar chain marker as measure of disease conditions of hepatic diseases |
05/23/2012 | EP2455099A1 Method of producing recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo |
05/23/2012 | EP2455087A2 Isolation and identification of heparan sulphate |
05/23/2012 | EP2454597A1 Therapeutic peptides, polypeptides ans nucleic acid sequences |
05/23/2012 | EP2454593A1 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
05/23/2012 | EP2454370A1 Microrna-24 |
05/23/2012 | EP2454367A2 Designer collagens and uses thereof |
05/23/2012 | EP2454282A1 Acylated glucagon analogues |
05/23/2012 | EP2454281A2 Masp isoforms as inhibitors of complement activation |
05/23/2012 | EP2454280A2 Serum markers associated with early and other stages of breast cancer |
05/23/2012 | EP2454279A1 Modified photoproteins with increased affinity for calcium and enhanced bioluminescence and uses thereof |
05/23/2012 | EP2454278A1 Novel fatty acid desaturases and elongases and uses thereof |
05/23/2012 | EP2454277A1 Regulation of zinc deficiency and tolerance in plants |
05/23/2012 | EP2454276A1 Therapeutic agents |
05/23/2012 | EP2454275A1 Process and system for obtaining botulinum neurotoxin |
05/23/2012 | EP2454274A1 Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting |
05/23/2012 | EP2454273A2 A mechanism and method for regulating glycogen synthase kinase 3 (gsk3)-related kinases |
05/23/2012 | EP2453923A2 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
05/23/2012 | EP2453918A2 Rsv f protein compositions and methods for making same |
05/23/2012 | EP2453915A1 Treatment of infections |
05/23/2012 | EP2453909A2 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
05/23/2012 | EP2453908A2 Bifunctional stapled polypeptides and uses thereof |
05/23/2012 | EP2453735A2 Dual vector for inhibition of human immunodeficiency virus |
05/23/2012 | EP1848731B1 Antibiotic 107891, its factors, pharmaceutically acceptable salts and compositions, and use thereof |
05/23/2012 | EP1800289B1 Single -pass image warping system and method with anisotropic filtering |
05/23/2012 | EP1675613B1 Hiv vaccines based on env of multiple clades of hiv |
05/23/2012 | EP1601374B2 Compositions and methods for diagnosing and treating an inflammation |
05/23/2012 | EP1576042B1 Optical information carrier comprising immobilized proteorhodopsin |
05/23/2012 | EP1567641B1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
05/23/2012 | EP1506222B2 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide, virus-like particles prepared therefrom and a method for preparing the particles |
05/23/2012 | EP1412750B1 T1r2-t1r3 hetero-oligomeric sweet taste receptors and cell lines that express said receptors and use thereof for identification of sweet taste compounds |
05/23/2012 | CN1950102B Modulation of cartilage homeostasis |
05/23/2012 | CN1720066B Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |